One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Defining rare conditions in the era of personalized medicine
Daniel J. O’Connor, Michela Gabaldo, Annemieke Aartsma-Rus & Anneliene Hechtelt Jonker
doi : 10.1038/d41573-023-00145-2
Volume 22 Issue 11, November 2023
CAR T cell therapies raise hopes — and questions — for lupus and autoimmune disease
Asher Mullard
MDMA-assisted therapy for PTSD passes phase III trial
Asher Mullard
Genetic support for FDA-approved drugs over the past decade
Polina V. Rusina, Maria J. Falaguera, Juan Maria R. Romero, Ellen M. McDonagh, Ian Dunham & David Ochoa
Drug delivery systems for CRISPR-based genome editors
Victoria Madigan, Feng Zhang & James E. DahlmanÂ
Artificial intelligence for natural product drug discovery
Michael W. Mullowney, Katherine R. Duncan, Somayah S. Elsayed, Neha Garg, Justin J. J. van der Hooft, Nathaniel I. Martin, David Meijer, Barbara R. Terlouw, Friederike Biermann, Kai Blin, Janani Durairaj, Marina Gorostiola González, Eric J. N. Helfrich, Florian Huber, Stefan Leopold-Messer, Kohulan Rajan, Tristan de Rond, Jeffrey A. van Santen, Maria Sorokina, Marcy J. Balunas, Mehdi A. Beniddir, Doris A. van Bergeijk, Laura M. Carroll, Chase M. Clark, …Marnix H. MedemaÂ
Therapeutic approaches for Duchenne muscular dystrophy
Thomas C. Roberts, Matthew J. A. Wood & Kay E. DaviesÂ
doi : .1038/s41573-023-00775-6
Author Correction: Bridging the gap between innovation and later-stage financing for biotech in Europe
Jing Gong, Jean-Loup Romet-Lemonne & Brandy HouserÂ
Author Correction: Disease modification in inflammatory skin disorders: opportunities and challenges
Thomas BieberÂÂ
